The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Multifaceted link between cancer and inflammation
Abstract
Increasing evidence from epidemiological, preclinical and clinical studies suggests that dysregulated inflammatory response plays a pivotal role in a multitude of chronic ailments including cancer. The molecular mechanism(s) by which chronic inflammation drives cancer initiation and promotion include increased production of pro-inflammatory mediators, such as cytokines, chemokines, reactive oxygen intermediates, increased expression of oncogenes, COX-2 (cyclo-oxygenase-2), 5-LOX (5-lipoxygenase) and MMPs (matrix metalloproteinases), and pro-inflammatory transcription factors such as NF-κB (nuclear factor κB), STAT3 (signal transducer and activator of transcription 3), AP-1 (activator protein 1) and HIF-1α (hypoxia-inducible factor 1α) that mediate tumour cell proliferation, transformation, metastasis, survival, invasion, angiogenesis, chemoresistance and radioresistance. These inflammation-associated molecules are activated by a number of environmental and lifestyle-related factors including infectious agents, tobacco, stress, diet, obesity and alcohol, which together are thought to drive as much as 90% of all cancers. The present review will focus primarily on the role of various inflammatory intermediates responsible for tumour initiation and progression, and discuss in detail the critical link between inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–215 of 215
Geborek, P., Nitelius, E., Noltorp, S., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.036715 · Cited by 58
Association between Cyclooxygenase expression and colorectal adenoma characteristics.
Einspahr, J. G., Krouse, R. S., Yochim, J. M., Danenberg, P. V., Danenberg, K. D., Bhattacharyya, A. K., Martı́nez, M. E., & Alberts, D. S. (2003) · PubMed · Cited by 52
An overview on the expression of cyclooxygenase-2 in tumors of the head and neck
Mendes, R. A., Carvalho, J. F. C., & van der Waal, I. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.03.016 · Cited by 50
The IκB kinase- a bridge between inflammation and cancer
Michael, M., & Karin (2008) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 49
Yu, Y., & Xiaoyan, X. (2007) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000236259.88146.a4 · Cited by 45
Expression patterns of 5‐lipoxygenase in human brain with traumatic injury and astrocytoma
Zhang, L., Zhang, W., Hu, H., et al. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00658.x · Cited by 42
Kalthoff, H., Roeder, C., Gieseking, J., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8972 · Cited by 39
Overexpression of cyclooxygenase‐2 in multiple myeloma: Association with reduced survival
Çetın, M., Buyukberber, S., Demir, M., Sarı, İ., Sari, I., Denız, K., Eser, B., Altuntaş, F., Camcı, C., Öztürk, A., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20460 · Cited by 35
Digel, W., Schöniger, W., Štefanič, M., Janssen, H., Buck, C., Schmid, M., Raghavachar, A., & Porzsolt, F. (1990) · Blood · doi:10.1182/blood.v76.8.1607.1607 · Cited by 34
Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma.
Faronato, M., Muzzonigro, G., Milanese, G., Menna, C., Bonfigli, A. R., Catalano, A., & Procopio, A. D. (2007) · PubMed · doi:10.14670/hh-22.1109 · Cited by 32
Enhanced cell motility and invasion of chicken embryo fibroblasts in response to JUN over‐expression
Bos, T. J., Margiotta, P., Bush, L., & Wasilenko, W. J. (1999) · International Journal of Cancer · Cited by 32
Ishikawa, H., Tsuyama, N., Obata, M., & Kawano, M. (2006) · Journal of Clinical and Experimental Hematopathology · doi:10.3960/jslrt.46.55 · Cited by 32
Liu, R. Y., Fan, C., Mitchell, S., et al. (1998) · PubMed · Cited by 29
Marengo, S. R., Sikes, R. A., Anezinis, P., Chang, S., & Chung, L. W. K. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199707)19:3<204::aid-mc8>3.0.co;2-d · Cited by 27
Hu, Z., Wen, J., Shen, M., & Liu, Y. (2006) · PubMed · Cited by 11
Cited by
TNF-α signalling and inflammation: interactions between old acquaintances
Zelová, H., & Hošek, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0633-0 · Cited by 853
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationThe Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Self-citationShanmugam, M. K., Dai, X., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.006 · Cited by 327
Self-citationChronic adipose tissue inflammation: all immune cells on the stage
Cildir, G., Akıncılar, S. C., & Tergaonkar, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.001 · Cited by 317
Self-citation
Metadata
- Authors
- Sethi, G., Shanmugam, M. K., Ramachandran, L., Kumar, A. P., & Tergaonkar, V.
- Venue
- Bioscience Reports
- Publisher
- Portland Press Ltd.
- Published
- 2011-09-26
- Volume
- 32
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0144-8463 (ISSN-L)
- 1573-4935
- OpenAlex
- W2029397966
- Cited by
- 333
- References
- 215
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.